Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
SARS-CoV-2 infection of sustentacular cells disrupts olfactory signaling pathways
Abhishek Kumar Verma, Jian Zheng, David K. Meyerholz, Stanley Perlman
Abhishek Kumar Verma, Jian Zheng, David K. Meyerholz, Stanley Perlman
View: Text | PDF
Research Article COVID-19

SARS-CoV-2 infection of sustentacular cells disrupts olfactory signaling pathways

  • Text
  • PDF
Abstract

Loss of olfactory function has been commonly reported in SARS-CoV-2 infections. Recovery from anosmia is not well understood. Previous studies showed that sustentacular cells, and occasionally olfactory sensory neurons (OSNs) in the olfactory epithelium (OE), are infected in SARS-CoV-2–infected patients and experimental animals. Here, we show that SARS-CoV-2 infection of sustentacular cells induces inflammation characterized by infiltration of myeloid cells to the olfactory epithelium and variably increased expression of proinflammatory cytokines. We observed widespread damage to, and loss of cilia on, OSNs, accompanied by downregulation of olfactory receptors and signal transduction molecules involved in olfaction. A consequence of OSN dysfunction was a reduction in the number of neurons in the olfactory bulb expressing tyrosine hydroxylase, consistent with reduced synaptic input. Resolution of the infection, inflammation, and olfactory dysfunction occurred over 3–4 weeks following infection in most but not all animals. We also observed similar patterns of OE infection and anosmia/hyposmia in mice infected with other human coronaviruses such as SARS-CoV and MERS-CoV. Together, these results define the downstream effects of sustentacular cell infection and provide insight into olfactory dysfunction in COVID-19–associated anosmia.

Authors

Abhishek Kumar Verma, Jian Zheng, David K. Meyerholz, Stanley Perlman

×

Figure 3

SARS-CoV-2 infection leads to altered signal transduction gene expression and cilia damage in OE.

Options: View larger image (or click on image) Download as PowerPoint
SARS-CoV-2 infection leads to altered signal transduction gene expressio...
(A) Bar graph shows expression profile of signal transduction molecules in SARS2-N501YMA30–infected OE at different time analyzed by qPCR. Data show significantly decreased expression of ACIII, Cnga2, and Golf at 2 dpi. Data represent mean ± SEM of results pooled from 2 independent experiments with mock (10 mice); 2, 6, and 12 dpi (8 mice); and 22 dpi (12 mice). Data were analyzed using Mann-Whitney U tests. *P < 0.05, **P < 0.01. (B) Cilia in OE were examined by staining for acetylated β-tubulin (green). Arrow marks damaged cillia. Scale bar: 50 μm. (C) SEM analysis shows well-aligned lawn of cilia in mock-infected OE but damaged cilia at 4 dpi. Scale bar: 1 mm (upper panels) and 3 μm (lower panels). Arrow shows enlarged view of smaller bracketed area. Scale bar was generated during data acquisition. (B and C) Data are representative of 4 mice.

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts